Skip to content

Rapid Micro Biosystems RPID Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
Ginkgo Bioworks logo
Ginkgo BioworksDNA
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
WAT
Waters CorporationWAT

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's operating lease right-of-use assets in other assets?
Rapid Micro Biosystems (RPID) reported operating lease right-of-use assets in other assets of $3.72M in Q1 2026.
How has Rapid Micro Biosystems's operating lease right-of-use assets in other assets changed year-over-year?
Rapid Micro Biosystems's operating lease right-of-use assets in other assets decreased by 21.7% year-over-year, from $4.75M to $3.72M.
What is the long-term trend for Rapid Micro Biosystems's operating lease right-of-use assets in other assets?
Over 3 years (2022 to 2025), Rapid Micro Biosystems's operating lease right-of-use assets in other assets has grown at a -16.1% compound annual growth rate (CAGR), from $6.75M to $3.98M.